同和药业
(300636)
| 流通市值：25.86亿 | | | 总市值：29.56亿 |
| 流通股本：3.67亿 | | | 总股本：4.20亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 383,163,489.97 | 184,392,671.37 | 828,659,350.98 | 636,241,288.48 |
| 营业总成本 | 357,376,905.98 | 167,876,632.18 | 702,520,673.31 | 520,768,052.25 |
| 其他经营收益 | | | | |
| 营业利润 | 20,080,426.04 | 19,615,993.9 | 74,894,385.22 | 91,735,058.4 |
| 利润总额 | 20,577,856.3 | 19,615,993.9 | 75,576,727.44 | 92,417,400.62 |
| 净利润 | 24,570,982.63 | 18,779,502.71 | 73,091,433.31 | 83,664,591.04 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 24,570,982.63 | 18,779,502.71 | 73,091,433.31 | 83,664,591.04 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,298,219,464.85 | 1,433,803,022.48 | 1,461,727,700.92 | 1,490,389,022.33 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,880,361,088.44 | 1,877,817,922.38 | 1,859,305,914.44 | 1,767,962,182.25 |
| 资产总计 | 3,178,580,553.29 | 3,311,620,944.86 | 3,321,033,615.36 | 3,258,351,204.58 |
| 流动负债: | | | | |
| 流动负债合计 | 673,186,757.07 | 787,920,144.82 | 666,921,271.86 | 582,555,347.13 |
| 非流动负债: | | | | |
| 非流动负债合计 | 132,386,225.8 | 139,686,649.74 | 288,877,695.91 | 299,988,052.13 |
| 负债合计 | 805,572,982.87 | 927,606,794.56 | 955,798,967.77 | 882,543,399.26 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,373,007,570.42 | 2,384,014,150.3 | 2,365,234,647.59 | 2,375,807,805.32 |
| 股东权益合计 | 2,373,007,570.42 | 2,384,014,150.3 | 2,365,234,647.59 | 2,375,807,805.32 |
| 负债和股东权益合计 | 3,178,580,553.29 | 3,311,620,944.86 | 3,321,033,615.36 | 3,258,351,204.58 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 403,830,605.75 | 194,284,667.55 | 830,137,521.27 | 607,846,011.87 |
| 经营活动现金流出小计 | 312,708,929.83 | 171,822,012.65 | 628,066,783.76 | 414,664,396.73 |
| 经营活动产生的现金流量净额 | 91,121,675.92 | 22,462,654.9 | 202,070,737.51 | 193,181,615.14 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 454,872,959.17 | 164,277,519.35 | 600,038,022.72 | 467,217,368.12 |
| 投资活动现金流出小计 | 410,632,134.62 | 298,197,822.39 | 616,946,774.65 | 435,575,994.9 |
| 投资活动产生的现金流量净额 | 44,240,824.55 | -133,920,303.04 | -16,908,751.93 | 31,641,373.22 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 122,997,053 | 59,712,000 | 469,890,512.13 | 358,014,762.13 |
| 筹资活动现金流出小计 | 328,554,751.16 | 86,664,175.71 | 567,855,028.09 | 507,117,084.41 |
| 筹资活动产生的现金流量净额 | -205,557,698.16 | -26,952,175.71 | -97,964,515.96 | -149,102,322.28 |
| 汇率变动对现金及现金等价物的影响 | -6,535,543.07 | -4,187,012.02 | 233,576.1 | 1,405,439.24 |
| 现金及现金等价物净增加额 | -76,730,740.76 | -142,596,835.87 | 87,431,045.72 | 77,126,105.32 |
| 期末现金及现金等价物余额 | 176,112,542.72 | 110,246,447.61 | 252,843,283.48 | 242,538,343.08 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -76,730,740.76 | - | 87,431,045.72 | - |
最新报告期：2026-09-08| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中泰证券 | 祝嘉琦 | 0.12 | 0.20 | 0.26 | 2026-09-08 |
| 华创证券 | 郑辰,王宏雨 | 0.21 | 0.26 | 0.31 | 2026-09-04 |